Branded placeholder — the logo and product name on the approved vial render, not yet studio photography.
Weight Loss
AOD-9604 / MOTS-C / Tesamorelin
Injectable, 1.2mg/2mg/3mg per mL, 5mL vial
$254/mo*/ month
A three-compound formulation combining AOD-9604, MOTS-C, and Tesamorelin, available by prescription for patients in a weight-management–focused treatment plan.
Availability and appropriateness are determined by a licensed provider following your intake review. Not all patients qualify for every treatment.
Working copy. This wording is pending a compliance and legal review. It is not final and may change before launch.
Prescription-only. Dispensed only if a licensed provider determines treatment is appropriate. No outcome is guaranteed.
* Price reflects the standard monthly subscription for this treatment. Availability and final pricing are confirmed by your provider during intake review — if a prescription isn't appropriate for you, you aren't charged.